Rhythm Pharmaceuticals Inc’s filing revealed that its Chief Human Resources Officer Cramer Pamela J. unloaded Company’s shares for reported $1.25 million on Apr 08 ’25. In the deal valued at $60.14 per share,20,760 shares were sold. As a result of this transaction, Cramer Pamela J. now holds 19,209 shares worth roughly $1.19 million.
Then, Mazabraud Yann sold 17,750 shares, generating $1,082,497 in total proceeds. Upon selling the shares at $60.99, the EVP, Head of International now owns 22,620 shares.
Before that, PAMELA CRAMER bought 20,760 shares. Rhythm Pharmaceuticals Inc shares valued at $1,140,970 were divested by the Officer at a price of $54.96 per share.
BofA Securities upgraded its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy from a a Neutral in a research note published recently. Jefferies began covering RYTM with “Buy” recommendation on January 02, 2025. Oppenheimer started covering the stock on December 20, 2024. It rated RYTM as “an Outperform”.
Price Performance Review of RYTM
On Tuesday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock jump 3.24% to $62.09. Over the last five days, the stock has gained 7.55%. Rhythm Pharmaceuticals Inc shares have risen nearly 10.91% since the year began. Nevertheless, the stocks have risen 53.95% over the past one year. While a 52-week high of $68.58 was reached on 04/08/25, a 52-week low of $35.17 was recorded on 04/07/25. SMA at 50 days reached $54.72, while 200 days put it at $52.91.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 60.63, which if violated will result in even more drops to 59.17. On the upside, there is a resistance level at 63.19. A further resistance level may holdings at 64.29. The Relative Strength Index (RSI) on the 14-day chart is 63.09, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.41, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 5.93%. Stochastics %K at 85.38% indicates the stock is a selling.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-03-31, dropping by -0.49 million shares to a total of 4.66 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 5.15 million shares. There was a decline of -10.5%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 21, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $70 price target.
